TechCrunch
plus-bold
TechCrunch
Open Navigation
TechCrunch
turing pharmaceuticals
A $750 Pill And Its Brash Owner Get Competition — And It Costs $1
Oct 23, 2015
Connie Loizos
Turing Pharmaceuticals, a months-old biotech startup that is largely financed by its 32-year-old founder and CEO Martin Shkreli, sparked widespread outrage last month. The reason: shortly after pay